These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35595620)

  • 21. Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma.
    Bozec A; Ilie M; Dassonville O; Long E; Poissonnet G; Santini J; Chamorey E; Ettaiche M; Chauvière D; Peyrade F; Hebert C; Benezery K; Sudaka A; Haudebourg J; Selva E; Hofman P
    Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2745-9. PubMed ID: 23430081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
    Payne K; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
    Head Neck; 2022 Nov; 44(11):2545-2554. PubMed ID: 35932094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
    Garrel R; Mazel M; Perriard F; Vinches M; Cayrefourcq L; Guigay J; Digue L; Aubry K; Alfonsi M; Delord JP; Lallemant B; Even C; Daurès JP; Landais P; Cupissol D; Alix-Panabières C
    Clin Chem; 2019 Oct; 65(10):1267-1275. PubMed ID: 31387885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells in oral squamous cell carcinoma: An insight.
    Prakruthi BV; Babu NC
    Indian J Cancer; 2015; 52(2):232-4. PubMed ID: 26853418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
    Tinhofer I; Hristozova T; Stromberger C; Keilhoiz U; Budach V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e685-90. PubMed ID: 22583603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment.
    Poellmann MJ; Bu J; Kim D; Iida M; Hong H; Wang AZ; Wheeler DL; Kimple RJ; Hong S
    Cancer Lett; 2023 May; 562():216187. PubMed ID: 37068555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer.
    Curtin J; Wong G; Wang W; Thomson P; Lam AK; Choi SW
    J Oral Pathol Med; 2022 Mar; 51(3):249-255. PubMed ID: 34586677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Wang HM; Wu MH; Chang PH; Lin HC; Liao CD; Wu SM; Hung TM; Lin CY; Chang TC; Tzu-Tsen Y; Hsieh JC
    Head Neck; 2019 Aug; 41(8):2676-2687. PubMed ID: 30903634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Sinoquet L; Jacot W; Gauthier L; Pouderoux S; Viala M; Cayrefourcq L; Quantin X; Alix-Panabières C
    Clin Chem; 2021 Nov; 67(11):1503-1512. PubMed ID: 34355741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
    Payne K; Brooks J; Batis N; Khan N; El-Asrag M; Nankivell P; Mehanna H; Taylor G
    Br J Cancer; 2023 Nov; 129(10):1590-1598. PubMed ID: 37735243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ
    Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.